Data acquisition for the histoculture drug response assay in lung cancer

A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer.

M. Fukuoka, H Niitani, Atsushi Suzuki et al. · Journal of Clinical Oncology · 1992 · 435 citations

Medicine, Oncology, Pharmacology +16

Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study.

Raymond P. Abratt, W. R. Bezwoda, Geoffrey Falkson et al. · Journal of Clinical Oncology · 1994 · 361 citations

Medicine, Oncology, Pharmacotherapy +17

Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs

Takefumi Kikuchi, Yataro Daigo, Toyomasa Katagiri et al. · Oncogene · 2003 · 323 citations

Medicine, Molecular Biology, Oncology +16

Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer.

Frank V. Fossella, J S Lee, William K. Murphy et al. · Journal of Clinical Oncology · 1994 · 223 citations

Medicine, Oncology, Pharmacology +16

Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer.

Prudence A. Francis, James R. Rigas, Mark G. Kris et al. · Journal of Clinical Oncology · 1994 · 218 citations

Pharmacy, Oncology, Pharmacotherapy +17